X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (31) 31
transplantation (25) 25
humans (24) 24
kidney transplantation (21) 21
male (18) 18
female (17) 17
middle aged (16) 16
surgery (16) 16
antibody-mediated rejection (15) 15
adult (12) 12
graft rejection - immunology (12) 12
immunology (11) 11
hla antibodies (10) 10
kidneys (10) 10
treatment outcome (10) 10
aged (8) 8
biopsy (8) 8
time factors (8) 8
antibodies (7) 7
complement (7) 7
graft rejection (7) 7
hla antigens - immunology (7) 7
risk factors (7) 7
graft rejection - diagnosis (6) 6
graft rejection - prevention & control (6) 6
urology & nephrology (6) 6
abridged index medicus (5) 5
association (5) 5
biomarkers - blood (5) 5
donor-specific antibody (5) 5
immunoadsorption (5) 5
prospective studies (5) 5
retrospective studies (5) 5
analysis (4) 4
bortezomib (4) 4
c4d (4) 4
cross-sectional studies (4) 4
double-blind method (4) 4
health aspects (4) 4
isoantibodies - blood (4) 4
kidney diseases (4) 4
kidney transplantation - adverse effects (4) 4
medicine (4) 4
medicine, research & experimental (4) 4
outcomes (4) 4
positive cross-match (4) 4
recipients (4) 4
rejection (4) 4
renal-allografts (4) 4
rituximab (4) 4
syngeneic grafts (4) 4
transplants & implants (4) 4
animals (3) 3
antibodies, monoclonal, humanized - therapeutic use (3) 3
austria (3) 3
c1 inhibitor (3) 3
cardiothoracic surgery (3) 3
chi-square distribution (3) 3
children (3) 3
complement activation (3) 3
drug administration schedule (3) 3
failure (3) 3
graft rejection - epidemiology (3) 3
graft-survival (3) 3
heart (3) 3
histocompatibility (3) 3
histocompatibility antigen hla (3) 3
humoral rejection (3) 3
immunoglobulins (3) 3
immunosuppression (3) 3
immunosuppressive agents - administration & dosage (3) 3
isoantibodies - immunology (3) 3
kidney (3) 3
kidney - pathology (3) 3
kidney-transplant recipients (3) 3
medicine, general & internal (3) 3
membrane filtration (3) 3
mycophenolate-mofetil (3) 3
peritransplant immunoadsorption (3) 3
predictive value of tests (3) 3
proportional hazards models (3) 3
renal-transplantation (3) 3
reproducibility of results (3) 3
survival (3) 3
therapy (3) 3
tissue donors (3) 3
viral antibodies (3) 3
abo blood-group system - blood (2) 2
alloantibodies (2) 2
antibodies - blood (2) 2
antibody (2) 2
antibody‐mediated rejection (2) 2
antigen-specific immunoadsorption (2) 2
apoptosis (2) 2
article (2) 2
austria - epidemiology (2) 2
biomedical engineering (2) 2
biopsies (2) 2
blood component removal - methods (2) 2
bone grafts (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Kidney International, ISSN 0085-2538, 03/2018, Volume 93, Issue 3, pp. 753 - 760
Catheter-related infections and dysfunction are the main catheter complications causing morbidity and mortality in hemodialysis patients. However, there are no... 
hemodialysis | tunneled catheter | taurolidine | catheter dysfunction | catheter-related infection | urokinase | ONCOLOGY-GROUP | METAANALYSIS | 4-PERCENT | PREVENTION | RANDOMIZED CONTROLLED-TRIAL | ANTIMICROBIAL LOCK | HEPARIN | TRISODIUM CITRATE | BACTEREMIA | UROLOGY & NEPHROLOGY | VASCULAR ACCESS | Drug Costs | Urokinase-Type Plasminogen Activator - therapeutic use | Prospective Studies | Taurine - economics | Humans | Middle Aged | Anticoagulants - economics | Heparin - therapeutic use | Male | Renal Dialysis - economics | Thiadiazines - adverse effects | Catheters, Indwelling - economics | Equipment Design | Thiadiazines - therapeutic use | Catheter-Related Infections - prevention & control | Thiadiazines - economics | Cost Savings | Austria | Time Factors | Fibrinolytic Agents - therapeutic use | Catheters, Indwelling - adverse effects | Catheter Obstruction - etiology | Heparin - economics | Adult | Female | Catheter-Related Infections - diagnosis | Taurine - therapeutic use | Catheterization, Central Venous - adverse effects | Taurine - adverse effects | Taurine - analogs & derivatives | Anti-Infective Agents - adverse effects | Catheter-Related Infections - economics | Risk Factors | Anti-Infective Agents - therapeutic use | Anticoagulants - therapeutic use | Central Venous Catheters - adverse effects | Treatment Outcome | Catheterization, Central Venous - economics | Central Venous Catheters - economics | Fibrinolytic Agents - economics | Catheter-Related Infections - microbiology | Cost-Benefit Analysis | Anti-Infective Agents - economics | Aged | Urokinase-Type Plasminogen Activator - economics | Catheter Obstruction - economics | Catheterization, Central Venous - instrumentation | Equipment Failure | Hypertension | Comorbidity | Hemodialysis | Cardiovascular disease | Infections | Catheters | Morbidity | Citric acid | U-Plasminogen activator | Studies | Microorganisms | Antibiotics | Diabetes | Kidney diseases | Heparin | Veins & arteries
Journal Article
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 07/2019, Volume 9, Issue 1, pp. 9762 - 11
Journal Article